Velzatinib demonstrates broad activity across KIT mutations in advanced gastrointestinal stromal tumours
Velzatinib demonstrates broad activity across KIT mutations in advanced gastrointestinal stromal tumours
Optimal panitumumab–bevacizumab sequencing evaluated in RAS wild-type metastatic colorectal cancer
Bupropion shows benefit for cancer-related fatigue in cancer survivors
Relacorilant chemo combination extends OS in platinum-resistant ovarian cancer
Aspirin in stage III colorectal cancer shows no significant DFS benefit but favourable safety
ASCO 2026: Latest in prostate cancer
Amivantamab in HPV-unrelated mHNSCC gives high response rates after immunotherapy and chemo
GLP-1 therapy associated with reduced breast cancer risk
Gene expression test guided therapy in ER+/HER2- early breast cancer allows safe chemotherapy omission
Tarlatamab in SCLC shows consistent effect and low immune toxicity across age groups
MCED blood test trial fails primary end point, but screening cut number of cancers found at stage IV
Fedratinib improves spleen and symptom responses with promising survival outcomes in MDS/MPN and CNL